Education
About Us
Working with TipRanks
Follow Us
Rapid Dose Therapeutics Corp (TSE:DOSE)
:DOSE
RESEARCH TOOLSreports
DOSE Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.13 - C$0.33
Previous CloseN/A
Volume31.00K
Average Volume (3M)16.06K
Market Cap
C$23.12M
Enterprise ValueC$37.34M
Total Cash (Recent Filing)C$6.17K
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta-0.35
Next Earnings
Jul 25, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding128,442,080
10 Day Avg. Volume11,965
30 Day Avg. Volume16,060
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)14.37
Price to Cash Flow (P/CF)-21.10
P/FCF Ratio78.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Rapid Dose Therapeutics Corp News
PremiumCompany Announcements
Rapid Dose Therapeutics Advances NFL-Funded Cannabinoid Research
PremiumCompany Announcements
Rapid Dose Therapeutics to Showcase XyliStrip at Canadian Dental Tradeshows
PremiumCompany Announcements
Rapid Dose Therapeutics to Settle Debt with Share Issuance
PremiumCompany Announcements
Rapid Dose Therapeutics Announces $5 Million Equity Financing Plan
PremiumCompany Announcements
Rapid Dose Therapeutics Updates Debt Settlement StrategyPremiumCompany Announcements
Rapid Dose Therapeutics to Issue Shares for Quarterly Interest on Debt
PremiumCompany Announcements
Rapid Dose Therapeutics Issues Shares to Settle Debt---
Options Prices
Currently, No data available
---
Ownership Overview
0.23% Insiders
―
Mutual Funds
― Other Institutional Investors
99.77% Public Companies and
Individual Investors
DOSE FAQ
What was Rapid Dose Therapeutics Corp’s price range in the past 12 months?
Rapid Dose Therapeutics Corp lowest stock price was C$0.13 and its highest was C$0.33 in the past 12 months.
What is Rapid Dose Therapeutics Corp’s market cap?
Rapid Dose Therapeutics Corp’s market cap is C$23.12M.
When is Rapid Dose Therapeutics Corp’s upcoming earnings report date?
Rapid Dose Therapeutics Corp’s upcoming earnings report date is Jul 25, 2025 which is in 92 days.
How were Rapid Dose Therapeutics Corp’s earnings last quarter?
Rapid Dose Therapeutics Corp released its earnings results on Jan 29, 2025. The company reported -C$0.011 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.011.
Is Rapid Dose Therapeutics Corp overvalued?
According to Wall Street analysts Rapid Dose Therapeutics Corp’s price is currently Overvalued.
Does Rapid Dose Therapeutics Corp pay dividends?
Rapid Dose Therapeutics Corp does not currently pay dividends.
What is Rapid Dose Therapeutics Corp’s EPS estimate?
Rapid Dose Therapeutics Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rapid Dose Therapeutics Corp have?
Rapid Dose Therapeutics Corp has 128,442,080 shares outstanding.
What happened to Rapid Dose Therapeutics Corp’s price movement after its last earnings report?
Rapid Dose Therapeutics Corp reported an EPS of -C$0.011 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -9.091%.
Which hedge fund is a major shareholder of Rapid Dose Therapeutics Corp?
Currently, no hedge funds are holding shares in TSE:DOSE
---
Company Description
Rapid Dose Therapeutics Corp
Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies designed to enhance outcomes and quality of lives in Canada. The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system to rapidly release active ingredients into the blood stream, such as pharmaceuticals, emulsified oils, and over-the-counter medicines; QuickStrip energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12 in the system; and QuickStrip sleep that delivers melatonin in the system. The company also provides product innovation, production, and consultation services to the nutraceutical, cannabis healthcare, and pharmaceutical manufacturing industries. It has a research partnership program with McMaster University for developing biopolymer compositions that can offer enhanced drug delivery performance when formulated in oral dissolvable thin films, as well as for developing orally delivered vaccine candidate for COVID-19. Rapid Dose Therapeutics Corp. is based in Burlington, Canada.
---
Technical Analysis
Canada Carbon
―
THC Biomed INTL
―
Neo Performance Materials Inc
―
HLS Therapeutics Inc
―
Cardiol Therapeutics
―
---